Expert reviews of omega-3’s and vitamin E hold promise for future of nutritional products market
“We are very gratified to see this recognition of omega-3 fatty acids and vitamin E by such authoritative nutrition leaders as the DRI committees in North America,” said William Turney, Head of Regulatory Affairs for DSM Nutritional Products North America, the world’s leading supplier of nutrients to the dietary supplement, food and beverage industries. “DSM has a deep commitment to the nutrition industry and strong confidence in its future.”
Because the DRI review process is lengthy and expensive, the DRI Committees must prioritize new DRI reviews. The criteria are evidence of significant, new, and relevant data published since the last DRI review, and relevance to current public health concerns.
In the case of long-chain omega-3 fatty acids, there is currently no DRI and establishment of a reference value would be useful because it would provide a parameter to assess the public’s status of these nutrients. A growing body of scientific evidence continues to show that long-chain omega-3 fatty acids may provide significant health benefits throughout life, including roles in infant development, cognition, eyesight and cardiovascular health. “How much is needed?” is the proverbial 64-thousand-dollar question.
“Establishment of a DRI for Omega-3’s will be a huge step forward for consumers, health care providers and manufacturers,” explained Will Black, Vice President of Marketing for DSM Nutritional Products, North America. “Once there are accepted reference values, appropriate guidelines for supplementation and fortified foods will be available, as well as guidelines for labeling and other forms of consumer communications.” He continued, “In the case of vitamin E, the current DRI was established in 2000 and needs to be revisited. Since then, thousands of studies have been conducted on vitamin E’s role in cardiovascular health, diabetes, eye health, immune function and more recently cognitive health.”
The U.S. and Canadian government agencies also announced a workshop in 2015 on the potential use of chronic disease endpoints in setting DRI values for the selected nutrients. This workshop will address whether and how chronic disease outcomes can be incorporated into setting DRI values, which would be a landmark in the history of the DRIs. Historically the DRIs, and formerly the RDAs, were viewed as the amount of a nutrient needed simply to prevent deficiency disease in the majority of the population. Accruing science through the past 20 years suggests that more liberal intakes of certain nutrients may have an impact on quality of life through the lifespan.
“Both an expert report on the potential of nutrients to reduce risk of chronic diseases and new DRIs will have a tremendous impact on the marketplace,” said Black. “They will give people a framework to evaluate whether they are getting enough of these critical nutrients in their diet.”
DSM – The global leader in nutritional lipid solutions
DSM, the world’s #1 ingredient supplier, offers the most complete portfolio of trusted nutritional lipids solutions addressing a full spectrum of health benefits, life stages and sources. DSM’s portfolio includes market-leading products Life’sARA™, life’sDHA™ and MEG-3® and has omega-3 solutions that will meet the needs of all types of foods, beverages, supplements and infant formulas worldwide. DSM’s nutritional lipids capabilities, from product forms to technologies for a range of applications and products, will be on display and available for sampling at Supply Side West show 2014 (being held on October 8 and 9 at Mandalay Bay Resort & Convention Center, Las Vegas, NV) along with DSM’s vast ingredients portfolio to help manufacturers meet the needs of health-conscious consumers around the world. To learn more about DSM’s nutritional lipids portfolio, please visit us at Supply Side West booth 23089 or call 1-800-526-0189. Additional information on our nutritional lipids can be found on www.dsm.com/human-nutrition.